[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Dream Beam


The Dream Beam Clinical Trials Are Progressing
Futrex announced that the calibration phase of the formal clinical trials of 
the Dream Beam non-invasive blood glucose meter is nearly completed. The 
initial data is now undergoing formal analysis. This analysis is to prove 
whether the Dream Beam Analyzer does satisfy the "Protocol" that was 
established between Futrex and the FDA. (The purpose of the formal clinical 
trials is to provide the scientific evidence required for submitting an 
application for FDA market clearance.)

The first half of the clinical trials involves calibrating the non-invasive 
Dream Beam instruments so that they then can be used for predictive purposes. 
Over 75 of approximately 140 Dream Beam units have completed calibration by 
individual volunteers in the privacy of their homes. They then returned the 
units to their designated principal investigator for calibration analysis.

Those Dream Beam units have now been returned to the volunteers and the 
predictive portion of the clinical trials (called a "validation phase") has 
commenced. It is expected that the validation phase will be completed in 
approximately 45 days.

In commenting on the initial results, Futrex stated that the Protocol requires 
proof that the Dream Beam Analyzer has accuracy at least as good as the finger 
stick meters used during the land-mark DCCT study. That study showed that 
performing four or more blood glucose tests per day could greatly diminish the 
dreaded complications of diabetes. .

The formal clinical trials are being conducted by three eminent independent 
principal investigators that are neither employees nor owners of any Futrex 
stock. Two of the Principal Investigators are diabetes researchers as well as 
medical doctors who treat a large number of diabetic patients. The third 
Principal Investigator is an internationally recognized expert in the field of 
utilizing near-infrared light to perform quantitative measurements.

Futrex is encouraged by the progress of the clinical trials. However, Futrex 
cautions that no definitive conclusion concerning the success of the formal 
clinical trials can be made until all the data is analyzed by the three 
independent Principal Investigators.

 This message sent to you from the desk of
  Yerachmiel Bruchya haLevi Altman's computer.

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml